PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer.
Journal Information
Full Title: Front Oncol
Abbreviation: Front Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."
"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Research reported in this publication was supported by grants from Tehran University of Medical Sciences (grants nos. 50756 and 50760, awarded to HM), and the National Institute for Medical Research Development (NIMAD) of Iran (grant no. 942554, awarded to JH)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025